Medical News

RSS
Kids around smokers lose more school days than peers

Kids around smokers lose more school days than peers

New head louse treatment shows promise

New head louse treatment shows promise

Diabetes prevention in five steps: Study

Diabetes prevention in five steps: Study

U.S. smoking rates on slow decline: CDC report

U.S. smoking rates on slow decline: CDC report

FDA stalls the blood-thinner Xarelto’s approval citing inadequate evidence

FDA stalls the blood-thinner Xarelto’s approval citing inadequate evidence

Discovery of a key protein’s role in cell clearance could impact future treatments of autoimmune diseases, obesity and atherosclerosis

Discovery of a key protein’s role in cell clearance could impact future treatments of autoimmune diseases, obesity and atherosclerosis

Robert Gordon University scientists to develop new treatment for cystinosis

Robert Gordon University scientists to develop new treatment for cystinosis

Month of birth may determine career

Month of birth may determine career

Brown fat may help curb obesity: Study

Brown fat may help curb obesity: Study

Chocolate protects heart but stirs debate on intake

Chocolate protects heart but stirs debate on intake

Walnuts may prevent breast cancer

Walnuts may prevent breast cancer

Tick-borne disease in US blood supply

Tick-borne disease in US blood supply

Youth immunization rates encouraging: CDC report

Youth immunization rates encouraging: CDC report

Sperm donors may father over 150 children

Sperm donors may father over 150 children

Mental health problems ail nearly half of all Americans: Report

Mental health problems ail nearly half of all Americans: Report

Positive results from BDSI's BEMA Buprenorphine/Naloxone formulation Phase 1 study on opioid dependence

Positive results from BDSI's BEMA Buprenorphine/Naloxone formulation Phase 1 study on opioid dependence

Golden Meditech launches Taiwan representative office

Golden Meditech launches Taiwan representative office

Discovery Labs files Complete Response to FDA for SURFAXIN to treat RDS in premature infants

Discovery Labs files Complete Response to FDA for SURFAXIN to treat RDS in premature infants

Enrollment complete in DURECT's POSIDUR Phase III study for post-surgical pain

Enrollment complete in DURECT's POSIDUR Phase III study for post-surgical pain

NINDS awards NeuroSigma STTR Phase I grant to support development of eTNS therapy for epilepsy

NINDS awards NeuroSigma STTR Phase I grant to support development of eTNS therapy for epilepsy

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.